Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area.
about
Phase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma.Validation of Roche LightCycler Epstein-Barr virus quantification reagents in a clinical laboratory setting.Complementary determination of Epstein-Barr virus DNA load and serum markers for nasopharyngeal carcinoma screening and early detection in individuals at risk in Tunisia.Epstein-Barr virus DNA quantification and follow-up in Tunisian nasopharyngeal carcinoma patients.
P2860
Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Role of Epstein-Barr virus DNA ...... carcinoma in a low risk area.
@ast
Role of Epstein-Barr virus DNA ...... carcinoma in a low risk area.
@en
type
label
Role of Epstein-Barr virus DNA ...... carcinoma in a low risk area.
@ast
Role of Epstein-Barr virus DNA ...... carcinoma in a low risk area.
@en
prefLabel
Role of Epstein-Barr virus DNA ...... carcinoma in a low risk area.
@ast
Role of Epstein-Barr virus DNA ...... carcinoma in a low risk area.
@en
P2093
P2860
P356
P1476
Role of Epstein-Barr virus DNA ...... l carcinoma in a low risk area
@en
P2093
J H J M van Krieken
J S Kalpoe
P B Douwes Dekker
P2860
P304
P356
10.1136/JCP.2005.030544
P407
P577
2006-02-17T00:00:00Z